Donna M. Mancini

Q: What Schools Are Affiliated With Donna M. Mancini

Donna M. Mancini is affiliated with the following schools: Albert Einstein College of Medicine, Icahn School of Medicine at Mount Sinai, Columbia University, Duke University, University of Pennsylvania

Donna M. Mancini's AcademicInfluence.com Rankings

Donna M. Mancini

Medical

#1570

World Rank

#1922

Historical Rank

Cardiology

#126

World Rank

#129

Historical Rank

medical Degrees

Donna M. Mancini

Philosophy

#4814

World Rank

#7466

Historical Rank

Logic

#2195

World Rank

#3131

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Why Is Donna M. Mancini Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Donna M. Mancini's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article (2005) (5001)
Value of Peak Exercise Oxygen Consumption for Optimal Timing of Cardiac Transplantation in Ambulatory Patients With Heart Failure (1991) (1705)
Use of a continuous-flow device in patients awaiting heart transplantation. (2007) (1631)
Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. (2010) (1439)
Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. (1996) (1192)
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. (2003) (1136)
Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. (2009) (837)
Outcomes of Left Ventricular Assist Device Implantation as Destination Therapy in the Post-REMATCH Era: Implications for Patient Selection (2007) (760)
Contribution of Skeletal Muscle Atrophy to Exercise Intolerance and Altered Muscle Metabolism in Heart Failure (1992) (745)
Validation of near-infrared spectroscopy in humans. (1994) (686)
Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): A Phase 2 Trial of Intracoronary Gene Therapy of Sarcoplasmic Reticulum Ca2+-ATPase in Patients With Advanced Heart Failure (2011) (659)
Decision Making in Advanced Heart Failure: A Scientific Statement From the American Heart Association (2012) (623)
A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators. (1998) (591)
Effect of Erythropoietin on Exercise Capacity in Patients With Moderate to Severe Chronic Heart Failure (2003) (565)
Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. (2010) (535)
Hemodilution Is Common in Patients With Advanced Heart Failure (2003) (477)
Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial. (2009) (453)
Report from a consensus conference on primary graft dysfunction after cardiac transplantation. (2014) (431)
Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. (1998) (426)
Use of Rapamycin Slows Progression of Cardiac Transplantation Vasculopathy (2003) (425)
Contribution of intrinsic skeletal muscle changes to 31P NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure. (1989) (409)
Consensus recommendations for the management of chronic heart failure: Introduction (1999) (391)
Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry. (2004) (383)
Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection (2020) (381)
Cardiac Improvement During Mechanical Circulatory Support: A Prospective Multicenter Study of the LVAD Working Group (2007) (377)
Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial. (2003) (371)
Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial (2015) (331)
Report from a consensus conference on antibody-mediated rejection in heart transplantation. (2011) (324)
High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. (2003) (320)
Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices: the Columbia ramp study. (2012) (311)
Respiratory Muscle Function and Dyspnea in Patients With Chronic Congestive Heart Failure (1992) (296)
Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity. (2004) (278)
Selection of Cardiac Transplantation Candidates in 2010 (2010) (265)
&bgr;-Blockers Restore Calcium Release Channel Function and Improve Cardiac Muscle Performance in Human Heart Failure (2003) (263)
Characterization of Myocardial Injury in Patients With COVID-19 (2020) (260)
Indirect recognition of donor HLA-DR peptides in organ allograft rejection. (1996) (259)
Task force 3: Recipient guidelines/prioritization (1993) (254)
Noninvasive detection of skeletal muscle underperfusion with near-infrared spectroscopy in patients with heart failure. (1989) (253)
Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody. (2000) (251)
Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure. (1999) (229)
Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. (2005) (227)
Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. (1997) (227)
Ventricular Assist Device Implantation Corrects Myocardial Lipotoxicity, Reverses Insulin Resistance, and Normalizes Cardiac Metabolism in Patients With Advanced Heart Failure (2012) (226)
Exertional Fatigue Due to Skeletal Muscle Dysfunction in Patients With Heart Failure (1993) (220)
Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure. (2008) (220)
Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices. (2010) (218)
Prevalence and Impact of Myocardial Injury in Patients Hospitalized with COVID-19 Infection (2020) (215)
Left Ventricular Assist Device as Destination for Patients Undergoing Intravenous Inotropic Therapy: A Subset Analysis From REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure) (2004) (212)
Use of a Wearable Defibrillator in Terminating Tachyarrhythmias in Patients at High Risk for Sudden Death: (2004) (208)
Relationship of muscular fatigue to pH and diprotonated Pi in humans: a 31P-NMR study. (1988) (200)
Relation of unrecognized hypervolemia in chronic heart failure to clinical status, hemodynamics, and patient outcomes. (2004) (199)
Randomized Trial of Empagliflozin in Non-Diabetic Patients with Heart Failure and Reduced Ejection Fraction. (2020) (198)
Left Ventricular Assist Devices: A Rapidly Evolving Alternative to Transplant. (2015) (195)
Bone loss and turnover after cardiac transplantation. (1997) (193)
Factors Associated With Primary Graft Failure After Heart Transplantation (2010) (189)
Osteoporosis and bone morbidity in cardiac transplant recipients. (1994) (187)
LVAD-induced reverse remodeling: basic and clinical implications for myocardial recovery. (2006) (185)
Prognostic Value of an Abnormal Signal‐Averaged Electrocardiogram in Patients With Nonischemic Congestive Cardiomyopathy (1993) (183)
Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current era. (2013) (176)
Cardiac rehabilitation exercise and self-care for chronic heart failure. (2013) (174)
Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist de vice (1999) (173)
Peak VO(2): a simple yet enduring standard. (2000) (158)
Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system. (2012) (151)
Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction. (2013) (147)
Fracture after cardiac transplantation: a prospective longitudinal study. (1996) (147)
Respiratory muscle deoxygenation during exercise in patients with heart failure demonstrated with near-infrared spectroscopy. (1991) (146)
Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction. (2012) (145)
The STARBRITE trial: a randomized, pilot study of B-type natriuretic peptide-guided therapy in patients with advanced heart failure. (2011) (142)
Reduced handgrip strength as a marker of frailty predicts clinical outcomes in patients with heart failure undergoing ventricular assist device placement. (2014) (138)
Effects of Continuous-Flow Versus Pulsatile-Flow Left Ventricular Assist Devices on Myocardial Unloading and Remodeling (2011) (137)
Immunologic sensitization in recipients of left ventricular assist devices. (2003) (134)
Improvement of myocardial mitochondrial function after hemodynamic support with left ventricular assist devices in patients with heart failure. (1998) (133)
Non-cardiac comorbidities in chronic heart failure (2006) (129)
Factors contributing to the exercise limitation of heart failure. (1993) (128)
Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients. (1999) (127)
Outcomes in cardiac transplant recipients using allografts from older donors versus mortality on the transplant waiting list; Implications for donor selection criteria. (2004) (122)
Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19 (2020) (122)
Pre-operative and post-operative risk factors associated with neurologic complications in patients with advanced heart failure supported by a left ventricular assist device. (2012) (120)
Detection of abnormal calf muscle metabolism in patients with heart failure using phosphorus-31 nuclear magnetic resonance. (1988) (119)
Use of telemonitoring to decrease the rate of hospitalization in patients with severe congestive heart failure. (1999) (118)
Is percentage of predicted maximal exercise oxygen consumption a better predictor of survival than peak exercise oxygen consumption for patients with severe heart failure? (1995) (117)
Validation of peak exercise oxygen consumption and the Heart Failure Survival Score for serial risk stratification in advanced heart failure. (2005) (116)
Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival. (2011) (115)
PRETRANSPLANT CACHEXIA AND MORBID OBESITY ARE PREDICTORS OF INCREASED MORTALITY AFTER HEART TRANSPLANTATION1 (2001) (113)
Heart allograft rejection: detection with breath alkanes in low levels (the HARDBALL study). (2004) (111)
In Vivo Magnetic Resonance Spectroscopy Measurement of Deoxymyoglobin During Exercise in Patients With Heart Failure: Demonstration of Abnormal Muscle Metabolism Despite Adequate Oxygenation (1994) (109)
Peak Cardiac Power Output, Measured Noninvasively, Is a Powerful Predictor of Outcome in Chronic Heart Failure (2009) (107)
Validity and Reliability of a Novel Slow Cuff-Deflation System for Noninvasive Blood Pressure Monitoring in Patients With Continuous-Flow Left Ventricular Assist Device (2013) (107)
Survival After Heart Transplantation Is Not Diminished Among Recipients With Uncomplicated Diabetes Mellitus: An Analysis of the United Network of Organ Sharing Database (2006) (104)
Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study. (1998) (104)
Ease of noninvasive measurement of cardiac output coupled with peak VO2 determination at rest and during exercise in patients with heart failure. (2007) (104)
Incidence and clinical significance of late right heart failure during continuous-flow left ventricular assist device support. (2015) (104)
Mechanical unloading leads to echocardiographic, electrocardiographic, neurohormonal, and histologic recovery. (2006) (104)
Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation. (2004) (103)
The Effect of Body Mass Index on Survival Following Heart Transplantation: Do Outcomes Support Consensus Guidelines? (2010) (101)
Dependence of enhanced maximal exercise performance on increased peak skeletal muscle perfusion during long-term captopril therapy in heart failure. (1987) (101)
Serial assessment of exercise capacity after heart transplantation. (1995) (97)
Predicting survival in ambulatory patients with severe heart failure on beta-blocker therapy. (2003) (97)
The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure. (2007) (92)
Mechanical Device–Based Methods of Managing and Treating Heart Failure (2005) (92)
Adipose Tissue Inflammation and Adiponectin Resistance in Patients With Advanced Heart Failure: Correction After Ventricular Assist Device Implantation (2012) (92)
Serial echocardiography using tissue Doppler and speckle tracking imaging to monitor right ventricular failure before and after left ventricular assist device surgery. (2013) (90)
Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation. (2017) (89)
Usefulness of two-dimensional echocardiographic parameters of the left side of the heart to predict right ventricular failure after left ventricular assist device implantation. (2012) (88)
Heart rhythm considerations in heart transplant candidates and considerations for ventricular assist devices: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006. (2006) (88)
Cardiac allograft vasculopathy: advances in understanding its pathophysiology, prevention, and treatment (2004) (87)
Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF: From the EMPA-TROPISM Study. (2021) (85)
Long-term outcomes after cardiac transplantation: an experience based on different eras of immunosuppressive therapy. (2001) (84)
Bridge-to-Decision Therapy With a Continuous-Flow External Ventricular Assist Device in Refractory Cardiogenic Shock of Various Causes (2014) (84)
Detection and imaging of cardiac allograft vasculopathy. (2013) (84)
Cardiac Transplantation Using Extended-Donor Criteria Organs for Systemic Amyloidosis Complicated by Heart Failure (2007) (82)
Left ventricular assist device bridge-to-transplant network improves survival after failed cardiotomy. (1999) (82)
Cardiogenic Shock and Hyperinflammatory Syndrome in Young Males With COVID-19 (2020) (80)
Comparison of exercise performance in patients with chronic severe heart failure versus left ventricular assist devices. (1998) (80)
Outcome after orthotopic cardiac transplantation in adults with congenital heart disease. (1999) (80)
The Heart Failure Survival Score outperforms the peak oxygen consumption for heart transplantation selection in the era of device therapy. (2011) (79)
Selecting patients for heart transplantation: comparison of the Heart Failure Survival Score (HFSS) and the Seattle heart failure model (SHFM). (2011) (78)
24th Bethesda conference: Cardiac transplantation. Task Force 3: Recipient guidelines/prioritization. (1993) (78)
Intravenous Pulse Administration of Cyclophosphamide Is an Effective and Safe Treatment for Sensitized Cardiac Allograft Recipients (2002) (77)
Regional differences in recipient waitlist time and pre- and post-transplant mortality after the 2006 United Network for Organ Sharing policy changes in the donor heart allocation algorithm. (2014) (74)
Intravenous use of amrinone for the treatment of the failing heart. (1985) (74)
Impact of Center Volume on Outcomes of Left Ventricular Assist Device Implantation as Destination Therapy: Analysis of the Thoratec HeartMate Registry, 1998 to 2005 (2009) (74)
Long-term survival after cardiac retransplantation: a twenty-year single-center experience. (1999) (74)
Heart transplantation in human immunodeficiency virus-positive patients. (2009) (74)
Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical Trial (2019) (73)
Comparison of blood volume characteristics in anemic patients with low versus preserved left ventricular ejection fractions. (2008) (73)
Effects of cardiac transplantation on ventilatory response to exercise. (1992) (72)
Everolimus in de novo cardiac transplantation: pharmacokinetics, therapeutic range, and influence on cyclosporine exposure. (2003) (70)
Association of low ejection fraction with impaired verbal memory in older patients with heart failure. (2011) (70)
Use of Cardiopulmonary Stress Testing for Patients With Unexplained Dyspnea Post–Coronavirus Disease (2021) (70)
Randomized Controlled Trial of Sirolimus Conversion in Cardiac Transplant Recipients With Renal Insufficiency (2012) (69)
Prognostic significance and measurement of exercise-derived hemodynamic variables in patients with heart failure. (2007) (69)
Alternate waiting list strategies for heart transplantation maximize donor organ utilization. (2005) (68)
Prolonged donor ischemic time does not adversely affect long-term survival in adult patients undergoing cardiac transplantation. (2003) (68)
Safety, tolerability, and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil-based formulation of cyclosporine--results at 24 months after transplantation. (1999) (66)
Improved diabetic control in advanced heart failure patients treated with left ventricular assist devices (2011) (66)
Sex differences in patient acceptance of cardiac transplant candidacy. (1995) (66)
Assessment of submaximal exercise capacity in patients with left ventricular assist devices. (1996) (64)
Heart Retransplantation (2007) (64)
Anti-HLA antibodies in heart transplantation. (2003) (63)
A comparison of atrial arrhythmias after heart or double-lung transplantation at a single center: insights into the mechanism of post-operative atrial fibrillation. (2009) (63)
Impact of Current Management Practices on Early and Late Death in More Than 500 Consecutive Cardiac Transplant Recipients (2000) (62)
Association of device surface and biomaterials with immunologic sensitization after mechanical support. (2008) (62)
Recurrent remodeling after ventricular assistance: is long-term myocardial recovery attainable? (2000) (61)
Systemic and regional hemodynamic effects of captopril and milrinone administered alone and concomitantly in patients with heart failure. (1985) (60)
An immunological algorithm to predict risk of high-grade rejection in cardiac transplant recipients (1998) (60)
Severe vitamin D deficiency among heart and liver transplant recipients (2009) (58)
Alloantibodies in heart transplantation. (2009) (57)
Sleep disordered breathing in patients with acutely decompensated heart failure. (2009) (57)
Left ventricular longitudinal strain by speckle-tracking echocardiography is associated with treatment-requiring cardiac allograft rejection. (2014) (57)
Myocardial Recovery in Patients Receiving Contemporary Left Ventricular Assist Devices: Results From the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS). (2016) (57)
The Impact of Obesity on Patients Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices. (2016) (55)
The NHLBI REVIVE-IT study: Understanding its discontinuation in the context of current left ventricular assist device therapy. (2016) (55)
Prediction of heart transplant rejection with a breath test for markers of oxidative stress. (2004) (55)
Clenbuterol increases lean muscle mass but not endurance in patients with chronic heart failure. (2008) (55)
Testing new targets of therapy in advanced heart failure: the design and rationale of the Strategies for Tailoring Advanced Heart Failure Regimens in the Outpatient Setting: BRain NatrIuretic Peptide Versus the Clinical CongesTion ScorE (STARBRITE) trial. (2005) (54)
Nonselective β-Adrenergic Blockade With Carvedilol Does Not Hinder the Benefits of Exercise Training in Patients With Congestive Heart Failure (1997) (54)
Comparison of the incidence of de novo solid malignancies after heart transplantation to that in the general population. (2009) (54)
Anti-CD25 treatment and FOXP3-positive regulatory T cells in heart transplantation. (2007) (54)
Effect of clenbuterol on cardiac and skeletal muscle function during left ventricular assist device support. (2006) (54)
Long-term results of cardiac transplantation in patients 65 years of age and older: a comparative analysis. (2003) (54)
Angiotensin II-receptor blockade further reduces afterload safely in patients maximally treated with angiotensin-converting enzyme inhibitors for heart failure. (1997) (53)
Heart failure in women. (2004) (52)
Effect of balloon mitral valvuloplasty on exercise capacity, ventilation and skeletal muscle oxygenation. (1993) (52)
Cardiopulmonary exercise variables in diastolic versus systolic heart failure. (2008) (52)
Impact of long term left ventricular assist device therapy on donor allocation in cardiac transplantation. (2013) (52)
A multicenter study of noninvasive cardiac output by bioreactance during symptom-limited exercise. (2009) (51)
Late right heart failure during support with continuous-flow left ventricular assist devices adversely affects post-transplant outcome. (2015) (51)
Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the “Cardiac Benefits” of Empagliflozin Independent of its Hypoglycemic Activity? (2019) (51)
Increased Prevalence of Autoimmune Phenomena and Greater Risk for Alloreactivity in Female Heart Transplant Recipients (2001) (50)
Comparison of peak exercise oxygen consumption and the Heart Failure Survival Score for predicting prognosis in women versus men. (2007) (50)
Cardiac transplantation in patients with hypertrophic cardiomyopathy. (2012) (50)
Serum exosomal protein profiling for the non-invasive detection of cardiac allograft rejection. (2017) (50)
Combination of liver biopsy with MELD-XI scores for post-transplant outcome prediction in patients with advanced heart failure and suspected liver dysfunction. (2014) (49)
Improving outcomes in heart transplantation: the potential of proliferation signal inhibitors. (2005) (49)
Rationale for Treatment of Patients With Chronic Heart Failure With Adrenergic Blockade (1995) (49)
Pre-operative echocardiographic features associated with persistent mitral regurgitation after left ventricular assist device implantation. (2013) (48)
The effect of timing and graft dysfunction on survival and cardiac allograft vasculopathy in antibody-mediated rejection. (2016) (48)
The Imperfect Cytokine Storm (2020) (47)
Ig-Like Transcript 3 Regulates Expression of Proinflammatory Cytokines and Migration of Activated T Cells1 (2009) (47)
Treating Anemia in Older Adults With Heart Failure With a Preserved Ejection Fraction With Epoetin Alfa: Single-blind Randomized Clinical Trial of Safety and Efficacy (2013) (47)
Excessive weight gain in cardiac transplant recipients. (2006) (47)
T‐cell post‐transplantation lymphoproliferative disorders after cardiac transplantation: a single institutional experience (2004) (47)
Partial loading of the left ventricle during mechanical assist device support is associated with improved myocardial function, blood flow and metabolism and increased exercise capacity. (2002) (46)
Cardiac Donor Risk Factors Predictive of Short-Term Heart Transplant Recipient Mortality: An Analysis of the United Network for Organ Sharing Database. (2015) (45)
Heart transplantation in diabetic recipients: a decade review of 161 patients at Columbia Presbyterian. (2004) (45)
Central and peripheral components of cardiac failure. (1986) (45)
Effect of dobutamine on skeletal muscle metabolism in patients with congestive heart failure. (1990) (45)
Attenuation of the unfolded protein response and endoplasmic reticulum stress after mechanical unloading in dilated cardiomyopathy. (2015) (44)
Ventricular assist device implantation improves skeletal muscle function, oxidative capacity, and growth hormone/insulin-like growth factor-1 axis signaling in patients with advanced heart failure (2014) (43)
Human immunodeficiency virus infection and left ventricular assist devices: a case series. (2011) (43)
Acceptable recipient outcomes with the use of hearts from donors with hepatitis-B core antibodies. (2005) (43)
Rationale for treatment of patients with chronic heart failure with adrenergic blockade. (1996) (43)
Optical Coherence Tomographic Evaluation of Transplant Coronary Artery Vasculopathy With Correlation to Cellular Rejection (2014) (43)
Morbidity and mortality in diabetic patients following cardiac transplantation. (2003) (41)
Relation of preoperative serum albumin levels to survival in patients undergoing left ventricular assist device implantation. (2013) (41)
Outcome of cardiac transplantation in patients requiring prolonged continuous-flow left ventricular assist device support. (2015) (41)
Incidence and predictors of myocardial recovery on long-term left ventricular assist device support: Results from the United Network for Organ Sharing database. (2014) (41)
Effect of dichloroacetate on the exercise performance of patients with heart failure. (1988) (40)
Mortality remains high for outpatient transplant candidates with prolonged (>6 months) waiting list time. (1999) (40)
Risk stratification of ambulatory patients with advanced heart failure undergoing evaluation for heart transplantation. (2012) (39)
Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine--results at six months after transplantation. (1999) (39)
Ventricular assist device elicits serum natural IgG that correlates with the development of primary graft dysfunction following heart transplantation. (2017) (39)
Outcome of patients with cardiac sarcoidosis undergoing cardiac transplantation--single-center retrospective analysis. (2012) (38)
Multivariate analysis of factors affecting waiting time to heart transplantation. (1996) (38)
Implantable Cardioverter-Defibrillators in Patients With a Continuous-Flow Left Ventricular Assist Device: An Analysis of the INTERMACS Registry. (2017) (38)
Immunoglobulin M-to-Immunoglobulin G Anti-Human Leukocyte Antigen Class II Antibody Switching in Cardiac Transplant Recipients Is Associated With an Increased Risk of Cellular Rejection and Coronary Artery Disease (2005) (38)
Factors affecting long-term survival (>10 years) after cardiac transplantation in the cyclosporine era. (2001) (38)
Advanced heart failure in patients infected with human immunodeficiency virus: is there equal access to care? (2014) (37)
Management of pregnancy in the post-cardiac transplant patient. (2014) (37)
Ghrelin resistance occurs in severe heart failure and resolves after heart transplantation (2009) (37)
New-onset graft dysfunction after heart transplantation--incidence and mechanism-related outcomes. (2011) (36)
Asymmetric Pattern of Cerebrovascular Lesions in Patients After Left Ventricular Assist Device Implantation (2012) (35)
Report From a Forum on US Heart Allocation Policy (2015) (35)
Assessment of myocardial recovery in a patient with acute myocarditis supported with a left ventricular assist device: a case report. (2003) (35)
Prognostic impact of the addition of peak oxygen consumption to the Seattle Heart Failure Model in a transplant referral population. (2012) (35)
Ventricular assist device support as a bridge to heart transplantation in patients with giant cell myocarditis (2012) (35)
Zoledronic acid versus alendronate for the prevention of bone loss after heart or liver transplantation. (2012) (34)
Effect of pulmonary vascular resistance before left ventricular assist device implantation on short- and long-term post-transplant survival. (2015) (34)
Usefulness of peak exercise oxygen consumption and the heart failure survival score to predict survival in patients >65 years of age with heart failure. (2009) (34)
Preoperative Proteinuria and Reduced Glomerular Filtration Rate Predicts Renal Replacement Therapy in Patients Supported With Continuous-Flow Left Ventricular Assist Devices (2016) (34)
Usefulness of non-invasive measurement of cardiac output during sub-maximal exercise to predict outcome in patients with chronic heart failure. (2009) (34)
Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF) (2013) (33)
-Blockers Restore Calcium Release Channel Function and Improve Cardiac Muscle Performance in Human Heart Failure (2003) (33)
Myocardial Recovery in Patients Receiving Contemporary Left Ventricular Assist DevicesCLINICAL PERSPECTIVE (2016) (33)
Discontinuing Antiresorptive Therapy One Year after Cardiac Transplantation: Effect on Bone Density and Bone Turnover (2006) (33)
Modifications of skeletal muscle ryanodine receptor type 1 and exercise intolerance in heart failure. (2013) (32)
Effect of exercise duration on density and coupling of beta-adrenergic receptors on human mononuclear cells. (1989) (32)
Mediastinal radiation and adverse outcomes after heart transplantation. (2010) (32)
Supplementation of L-Alanyl-L-Glutamine and Fish Oil Improves Body Composition and Quality of Life in Patients With Chronic Heart Failure (2015) (31)
Indirect recognition of native HLA alloantigens and B-cell help. (1995) (31)
Cardiac transplantation in adult patients with mental retardation: do outcomes support consensus guidelines? (2012) (31)
The Changing Pattern of Humoral Rejection in Cardiac Transplant Recipients (2007) (30)
Neutrophil gelatinase-associated lipocalin and cystatin C for the prediction of clinical events in patients with advanced heart failure and after ventricular assist device placement. (2014) (30)
Higher rate of comorbidities after cardiac retransplantation contributes to decreased survival. (2009) (29)
Overcoming Electromagnetic Interference by LVADs on ICD Function by Shielding the ICD Programmer Wand and Extension Cable (2009) (29)
Outcomes of contemporary mechanical circulatory support device configurations in patients with severe biventricular failure. (2016) (29)
The role of implantable cardioverter defibrillators in patients bridged to transplantation with a continuous-flow left ventricular assist device: A propensity score matched analysis. (2017) (29)
Hemodynamic Response to Exercise in Patients Supported by Continuous Flow Left Ventricular Assist Devices. (2020) (29)
Preoperative Serum Albumin Levels Predict 1-Year Postoperative Survival of Patients Undergoing Heart Transplantation (2013) (29)
Aortic valve procedures at the time of ventricular assist device placement. (2011) (29)
Persistence of Cheyne-Stokes breathing after left ventricular assist device implantation in patients with acutely decompensated end-stage heart failure. (2007) (28)
Improved atrial function in bicaval versus standard orthotopic techniques in cardiac transplantation. (1997) (28)
Pilot study of guided imagery use in patients with severe heart failure. (2000) (28)
Plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1 are correlated with the presence of transplant coronary artery disease in cardiac transplant recipients. (1997) (28)
Foundation/American Heart Association Task Force on Practice Guidelines Heart Failure in Adults. A Report of the American College of Cardiology Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of (2009) (28)
Preoperative Assessment of High-Risk Candidates to Predict Survival After Heart Transplantation (2013) (28)
Comparison across races of peak oxygen consumption and heart failure survival score for selection for cardiac transplantation. (2010) (27)
Impact of Socioeconomic Status on Patients Supported With a Left Ventricular Assist Device: An Analysis of the UNOS Database (United Network for Organ Sharing). (2016) (27)
Sympathetic vasoconstriction during exercise in ambulatory patients with left ventricular failure. (1989) (27)
Assessment of synchrony relationships between the native left ventricle and the HeartMate left ventricular assist device. (2002) (27)
Value of Peak Exercise Oxygen Consumption Combined With B-type Natriuretic Peptide Levels for Optimal Timing of Cardiac Transplantation (2013) (27)
Atrial Fibrillation in Patients With Left Ventricular Assist Devices: Incidence, Predictors, and Clinical Outcomes. (2016) (27)
Management of Noncardiac Comorbidities in Chronic Heart Failure. (2015) (26)
Dynamics and prognostic role of galectin-3 in patients with advanced heart failure, during left ventricular assist device support and following heart transplantation (2016) (26)
Application of near infrared spectroscopy to the evaluation of exercise performance and limitations in patients with heart failure. (1997) (26)
Outcomes of Adult Patients With Congenital Heart Disease After Heart Transplantation: Impact of Disease Type, Previous Thoracic Surgeries, and Bystander Organ Dysfunction. (2016) (26)
Peak cardiac power measured noninvasively with a bioreactance technique is a predictor of adverse outcomes in patients with advanced heart failure. (2010) (26)
New Heart Failure Diagnoses Among Patients Hospitalized for COVID-19 (2021) (26)
Detection of skeletal muscle fatigue in patients with heart failure using electromyography. (1992) (26)
Should HIV-positive recipients undergo heart transplantation? (2003) (25)
Dobutamine stress echocardiography is inadequate to detect early cardiac allograft vasculopathy. (2016) (25)
Value of drug-eluting stents in cardiac transplant recipients. (2009) (25)
Coronavirus and Cardiometabolic Syndrome (2020) (25)
Challenges in heart transplantation during COVID-19: A single-center experience (2020) (24)
Pacemaker Implantation After Mitral Valve Surgery With Atrial Fibrillation Ablation. (2019) (24)
Value of Serial Echo‐Guided Ramp Studies in a Patient with Suspicion of Device Thrombosis after Left Ventricular Assist Device Implantation (2014) (23)
Is ventilatory classification preferable to peak oxygen consumption for risk stratification in heart failure? (2007) (23)
Incidence and Impact of On-Cardiopulmonary Bypass Vasoplegia During Heart Transplantation (2017) (23)
Coronavirus disease 2019 in heart transplant recipients: Risk factors, immunosuppression, and outcomes (2021) (22)
Use of isosorbide dinitrate and hydralazine in African-Americans with heart failure 9 years after the African-American Heart Failure Trial. (2014) (22)
Prevalence of polyreactive innate clones among graft--infiltrating B cells in human cardiac allograft vasculopathy. (2016) (22)
The effect of erythropoietin on exercise capacity, left ventricular remodeling, pressure-volume relationships, and quality of life in older patients with anemia and heart failure with preserved ejection fraction. (2009) (22)
Early use of remote dielectric sensing after hospitalization to reduce heart failure readmissions (2020) (22)
Hypersensitivity myocarditis and outcome after heart transplantation. (2013) (22)
Characterization of lymphocyte beta-adrenergic receptors at rest and during exercise in ambulatory patients with chronic congestive heart failure. (1989) (21)
Peak VO2 in elderly patients with heart failure. (2008) (21)
New methodologies to accurately assess circulating active transforming growth factor‐&bgr;1 levels: implications for evaluating heart failure and the impact of left ventricular assist devices (2017) (21)
Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failure. (1997) (21)
Surgically denervated cardiac transplant. Rewired or permanently unplugged? (1997) (21)
Effect of erythropoietin on exercise capacity in anemic patients with advanced heart failure. (2003) (21)
Markers of extracellular matrix turnover and the development of right ventricular failure after ventricular assist device implantation in patients with advanced heart failure. (2012) (20)
Morbidity and mortality of UNOS status 1B cardiac transplant candidates at home. (2003) (20)
Comparison of outcomes after heart replacement therapy in patients over 65 years old. (2015) (20)
Strategies of Wait-listing for Heart Transplant vs Durable Mechanical Circulatory Support Alone for Patients With Advanced Heart Failure. (2020) (20)
Dynamics of bone turnover markers in patients with heart failure and following haemodynamic improvement through ventricular assist device implantation (2012) (20)
Outcome of patients having heart transplantation for lymphocytic myocarditis. (2013) (20)
Growth hormone resistance in severe heart failure resolves after cardiac transplantation (2009) (20)
Should heart transplantation be considered as a treatment option for patients aged 70 years and older? (2004) (20)
Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy (2003) (19)
Outcomes of Multiple Listing for Adult Heart Transplantation in the United States: Analysis of OPTN Data From 2000 to 2013. (2015) (19)
Cardiac transplantation in over 1000 patients: a single institution experience from Columbia University. (1999) (19)
Treatment of anemia in patients with chronic heart failure. (2004) (19)
Characteristics and Outcomes of COVID-19 in Patients on Left Ventricular Assist Device Support (2021) (19)
Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for heart transplantation. (2014) (18)
National trends and outcomes in device-related thromboembolic complications and malfunction among heart transplant candidates supported with continuous-flow left ventricular assist devices in the United States. (2016) (18)
Mycophenolate mofetil reduces anti-HLA antibody production and cellular rejection in heart transplant recipients. (2002) (18)
Durability and clinical impact of tricuspid valve procedures in patients receiving a continuous-flow left ventricular assist device. (2016) (17)
Characteristics of patients with advanced heart failure having eosinophilic infiltration of the myocardium in the recent era. (2013) (16)
HFpEF: is splitting into distinct phenotypes by comorbidities the pathway forward? (2014) (16)
New developments for the detection and treatment of cardiac vasculopathy (2017) (16)
Prevalence and timing of bend relief disconnection in patients supported by the late version HeartMate II left ventricular assist device. (2013) (16)
Reduced myocardial blood flow during left ventricular assist device support: a possible cause of premature bypass graft closure. (2005) (16)
Skeletal muscle metabolic dysfunction : implications for exercise intolerance in heart failure (1993) (16)
Registry Evaluation of Vital Information for VADs in Ambulatory Life (REVIVAL): Rationale, design, baseline characteristics, and inclusion criteria performance. (2020) (16)
The PROCEED II International Heart Transplant Trial with the Organ Care System Technology (OCS) (2013) (16)
Insertion of a left ventricular assist device in patients without thorough transplant evaluations: a worthwhile risk? (2003) (16)
Cardiac Improvement During Mechanical Circulatory Support (2007) (16)
Perceived control and health-related quality of life in heart transplant recipients (2018) (15)
Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy. (1995) (15)
Concomitant aortic valve repair with continuous-flow left ventricular assist devices: Results and implications. (2016) (15)
Anti-Human Leukocyte Antigen Antibodies are Associated with Restenosis after Percutaneous Coronary Intervention for Cardiac Allograft Vasculopathy (2005) (15)
Inotropic Drugs for the Treatment of Heart Failure (1985) (14)
Older recipient age is associated with reduced alloreactivity and graft rejection after cardiac transplantation. (2001) (14)
Potential for donation after circulatory death heart transplantation in the United States: Retrospective analysis of a limited UNOS dataset (2020) (14)
Role of indirect allorecognition in chronic rejection of human allografts. (1996) (14)
Predictive Value of Cardiopulmonary Exercise Testing Parameters in Ambulatory Advanced Heart Failure. (2021) (14)
Infectious complications after cardiac transplantation in patients bridged with mechanical circulatory support devices versus medical therapy. (2016) (14)
Comparison of early versus delayed timing of left ventricular assist device implantation as a bridge-to-transplantation: An analysis of the UNOS dataset. (2016) (14)
Assessment of a University of California, Los Angeles 4‐Variable Risk Score for Advanced Heart Failure (2014) (14)
Effect of CYP2C9 and VKORC1 Gene Variants on Warfarin Response in Patients with Continuous-Flow Left Ventricular Assist Devices (2016) (14)
Dissociation between exercise hemodynamics and exercise capacity in patients with chronic heart failure and marked increase in ejection fraction after treatment with beta-adrenergic receptor antagonists. (2003) (14)
Comparison Between Cardiac Allograft Vasculopathy and Native Coronary Atherosclerosis by Optical Coherence Tomography. (2016) (13)
Safety and efficacy of everolimus (RAD) as part of a triple immunosuppressive regimen in de novo cardiac transplant recipients: six-month analysis (2002) (13)
Vascular inflammation and abnormal aortic histomorphometry in patients after pulsatile- and continuous-flow left ventricular assist device placement. (2016) (13)
Standardized Use of the Stanford Integrated Psychosocial Assessment for Transplantation in LVAD Patients. (2019) (13)
Vasopressor Response to Angiotensin II Infusion in Patients With Chronic Heart Failure Receiving &bgr;-Blockers (2003) (13)
Skeletal Muscle Changes in Chronic Cardiac Disease and Failure. (2015) (13)
Bethesda Conference: conference for the design of clinical trials to study circulatory support devices for chronic heart failure. (1998) (13)
Amiodarone Treatment Prior to Heart Transplantation Is Associated with Acute Graft Dysfunction and Early Mortality: A Propensity-Matched Comparison (2014) (12)
Increased Levels of Retinol Binding Protein 4 in Patients With Advanced Heart Failure Correct After Hemodynamic Improvement Through Ventricular Assist Device Placement (2012) (12)
Increased levels of retinol binding protein 4 in patients with advanced heart failure correct after hemodynamic improvement through ventricular assist device placement. (2011) (12)
Novel echocardiographic strategies for rejection diagnosis (2013) (12)
Use of Ventricular Assist Devices in Patients with Mitral Valve Prostheses (2011) (12)
Aortic regurgitation during systolic-phase accompanied by mitral regurgitation in patients with continuous-flow left ventricular assist device. (2013) (11)
Cardiac transplantation in a patient with protein S deficiency. (1999) (11)
Recovery of Serum Cholesterol Predicts Survival After Left Ventricular Assist Device Implantation (2016) (11)
Mechanical circulatory support as a bridge to cardiac retransplantation: a single center experience. (2015) (11)
New positive inotropic drugs for the treatment of congestive heart failure. (1985) (11)
Cardiac transplantation in an HIV-1-infected patient. (2003) (11)
The mechanism of extertional fatigue in heart failure. (1990) (10)
Periodontitis and bone metabolism in patients with advanced heart failure and after heart transplantation (2017) (10)
Treatment of anemia in patients with chronic heart failure (2003) (10)
Effect of peripheral vascular disease on mortality in cardiac transplant recipients (from the United Network of Organ Sharing Database). (2014) (10)
Late syphilis in a cardiac transplant patient. (2006) (10)
In vivo comparison between cardiac allograft vasculopathy and native atherosclerosis using near-infrared spectroscopy and intravascular ultrasound. (2015) (9)
T cell repertoire analysis suggests a prominent bystander response in human cardiac allograft vasculopathy (2020) (9)
Maximizing donor allocation: A review of UNOS region 9 donor heart turn‐downs (2017) (9)
Heart transplant allocation: in desperate need of revision. (2014) (9)
Survival of diabetic patients following cardiac transplant. (2001) (8)
Transcatheter mitral valve repair for functional mitral regurgitation: Evaluating the evidence. (2020) (8)
Does Renal Function Deteriorate More Rapidly in Diabetic Cardiac Transplant Recipients? (2007) (8)
Pretransplant evaluationDevelopment and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation (1996) (8)
Bridging cardiogenic shock patients with short-term ventricular support at a community hospital to long-term ventricular support at a tertiary hospital. (2012) (8)
Increased coronary lipid accumulation in heart transplant recipients with prior high-grade cellular rejection: novel insights from near-infrared spectroscopy (2016) (8)
Resting myocardial blood flow and metabolism predicts improved native left ventricular output and the ability to exercise with weaning in patients with the TCI heartmate left ventricular assist device (1999) (8)
Similar survival in patients following heart transplantation receiving induction therapy using daclizumab vs. basiliximab. (2015) (7)
Analysis of Skeletal Muscle Torque Capacity and Circulating Ceramides in Patients with Advanced Heart Failure. (2016) (7)
Electrical connection of native and transplanted sinus nodes via atrial to atrial pacing improves exercise performance after cardiac transplantation. (1998) (7)
511: Selection of UNOS Status 1A Candidates for Mechanical Circulatory Support as Bridge-to-Transplantation (BTT) – Analysis of UNOS/OPTN 2000-2005 (2008) (7)
Cardiac assist devices for end-stage heart failure. (2001) (6)
Abstract 2310: Peak Cardiac Power, Measured Non-Invasively, Is A Powerful Predictor Of Mortality In Chronic Heart Failure (2007) (6)
Sixteen years of cardiac transplantation: the Columbia Presbyterian Medical Center experience 1977 to 1993. (1993) (6)
Acylation of ghrelin is increased in heart failure and decreases post heart transplantation (2014) (6)
Left and Right Ventricular Functional Dynamics Determined by Echocardiograms Before and After Lung Transplantation. (2015) (6)
EVEROLIMUS IN DE NOVO CARDIAC TRANSPLANT RECIPIENTS: 24-MONTH FOLLOW-UP (2004) (6)
AHA Scientific Statement Clinician's Guide to Cardiopulmonary Exercise Testing in Adults A Scientific Statement From the American Heart Association (2010) (6)
Skeletal muscle atrophy contributes to exercise intolerance in heart failure (1991) (6)
Clinical benefits of long-term angiotensin II receptor blockade in patients with severe symptoms of congestive heart failure despite full angiotensin converting enzyme inhibition (1998) (6)
12 month report of a 3 arm multicenter comparison of Tacrolimus (TAC), MMF or TAC/Sirolimus(SRL) and steroids vs Cyclosporine microemulsion(CYA), MMF and steroids in de novo cardiac transplant recipients (2005) (6)
Utilization of Defibrillators and Resynchronization Therapy at the Time of Evaluation at a Heart Failure and Cardiac Transplantation Center (2010) (6)
Effect of Daclizumab induction therapy on the development of cardiac transplant vasculopathy. (2001) (6)
Impairment of Myocardial Glutamine Homeostasis Induced By Suppression of the Amino Acid Carrier SLC1A5 in Failing Myocardium. (2019) (6)
Peak VO2is superior to 6 minute walk for the prediction of survival in patients with heart failure (1996) (6)
Differences in Regional Recipient Waitlist Time and Pre- and Post-Transplant Mortality Following the 2006 UNOS Policy Changes in the Donor Heart Allocation Algorithm (2014) (5)
Patient selection for cardiac transplant in 2012 (2013) (5)
Hepatic Dysfunction in Ambulatory Patients with Heart Failure – Application of the MELD Scoring System for Outcome Prediction (2013) (5)
Intravenous immunoglobulin therapy in highly sensitized cardiac allograft recipients facilitates transplantation across donor specific IGG positive cross matches. (2001) (5)
Alteration in systemic vascular resistance and cardiac output during acute cellular rejection and recovery in heart transplant recipients. (2010) (5)
Efficacy of combined diuretic therapy with metolazone and furosemide in patients with refractory congestive heart failure (1986) (4)
The New Adult Heart Allocation Policy: A Work in Progress. (2020) (4)
Is Lactate Level during Warm Perfusion a Predictor for Post Transplant Outcomes (2013) (4)
Prevention of bone loss after cardiac transplantation with alendronate or calcitriol: efficacy and safety (2003) (4)
Cardiac transplant donor heart allocation based on prospective tissue matching. (1994) (4)
Relation of Left Ventricular Assist Device Infections With Cardiac Transplant Outcomes. (2021) (4)
Recombinant herpes zoster vaccine after heart transplantation: A single-center experience. (2020) (4)
Bridging to Transplant With Fully Implantable Biventricular Assist Devices vs. Total Artificial Heart Implantation in Patients With Advanced Biventricular Failure (2015) (4)
Lactate Dehydrogenase Isoenzyme Monitoring in Patients with Continuous-Flow Left Ventricular Assist Devices (CF-LVADs) (2016) (4)
Sustained Cardiac Recovery Hinges on Timing and Natural History of Underlying Condition (2018) (4)
Immunoglobulin Mto-Immunoglobulin G Anti-Human Leukocyte Antigen Class II Antibody Switching in Cardiac Transplant Recipients Is Associated With an Increased Risk of Cellular Rejection and Coronary Artery Disease (2005) (4)
Longitudinal profiling of circulating miRNA during cardiac allograft rejection: a proof‐of‐concept study (2021) (4)
Aortic Root Thrombus Formation in Patients with Continuous-Flow Left Ventricular Assist Devices (CF-LVADs) (2016) (4)
Treatment of anemia in the patient with heart failure (2005) (4)
Patients With End Stage Congestive Heart Failure Have Decreased High Molecular Weight Von Willebrand Factor Multimers and Higher Plasma Levels Of Total TGF-β1: Implantation Of a Left Ventricular Assist Devices (LVAD) Exacerbates Both Abnormalities (2013) (4)
Heart Transplantation After Ex-Vivo Perfusion of the Donor Hearts: Does it Affect Inotropic Use and Hospital Stay? (2014) (3)
518: The VentrAssist LVAD as a Bridge to Cardiac Transplantation: Results of the U.S. Feasibility Trial (2008) (3)
Predictors of Prolonged Status 1A Wait Time Prior to Heart Transplant (2013) (3)
Volumetric intravascular ultrasound assessment of mechanisms and results of stent expansion in heart transplant patients (2013) (3)
Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC. (2007) (3)
Objective detection of muscle fatigue in patients with heart failure (1991) (3)
Abstract 2308: Does Peak Oxygen Consumption add to the Seattle Heart Failure Model? (2007) (3)
Skeletal muscle metabolic abnormalities in congestive heart failure are not due to muscle atrophy (1991) (3)
Current experience with left ventricular assist devices in patients with congestive heart failure (1999) (3)
Driveline Infection Is Not Associated With Increased Risk of Thrombotic Events in CF-LVAD Patients (2015) (3)
Management of Non-cardiac Co-morbidities in Chronic Heart Failure (2015) (3)
Risk Score To Predict Survival to Hospital Discharge after Left-Ventricular Assist Device (LVAD) Implantation as Destination Therapy (DT) (2006) (3)
Malignancy Post Heart Transplantation: No Free Lunch. (2018) (3)
The Impact of Donor Specific Antibodies on Antibody Mediated Rejection (2016) (3)
Influence of donor-recipient HLA-DR matching on efficacy of anti-CD25 mAb in cardiac transplantation. (2001) (3)
De novo human leukocyte antigen allosensitization patterns in patients bridged to heart transplantation using left ventricular assist devices. (2022) (3)
Risk Factors for Mortality with Heart Failure (2012) (3)
Post-transplant survival estimation using pre-operative albumin levels. (2014) (3)
Increased risk for cardiac allograft rejection in recipients with HLA-B8, DR3 type. (2001) (3)
Abstract 15991: Multiple Listing Increases Access to Heart, Lung, Liver, and Kidney Transplantation (2015) (2)
Validity and Reliability of a Next Generation Non-Invasive Blood Pressure Monitor in Patients with Continuous-Flow Left Ventricular Assist Device (2016) (2)
Listing and treatment of status 1 patients (2001) (2)
Identifying Ambulatory Advanced Heart Failure Patients at High Risk for Death, LVAD or Transplant at 1-year: How Did the REVIVAL Eligibility Criteria Perform? (2018) (2)
Rapid Deterioration of Hospital-Acquired COVID-19 in a Patient on Extracorporeal Left Ventricular Assist Support (2020) (2)
Abstract 17340: Disparities in Wait Times for Heart Transplant by Racial and Ethnic Minorities (2018) (2)
Percutaneous balloon aortic valvuloplasty as a bridge to heart transplantation. (1993) (2)
Evaluation of cyclosporin (CsA) profiles month 2 to 6 in an international phase III randomized, multicenter, double-blind study of everolimus in DE novo heart transplant recipients (2005) (2)
Skeletal muscle underperfusion in heart failure is produced by exercise-induced muscle vasoconstriction (1991) (2)
Vitamin D deficiency is common in heart failure (1996) (2)
Management and Outcome of Left Ventricular Distention During Venoarterial Extracorporeal Membrane Oxygenation Support (2015) (2)
Severe coronary artery spasm presenting as Prinzmetal's angina following cardiac transplantation. (2018) (2)
From the American Heart Association Clinician's Guide to Cardiopulmonary Exercise Testing in Adults: A Scientific Statement (2013) (2)
58: Thyroid Deficiency Is Common in Advanced Heart Failure and Associated with Increased Operative Mortality after Assist Device Implantation (2010) (2)
Advanced Heart Failure Therapy in HIV Positive Patients: Do These Patients Get Equal Treatment? (2013) (2)
Ventricular assist (2014) (2)
Gene therapy for heart failure: an investigational treatment that is coming of age. (2010) (2)
The risk of transmission of hepatitis B from from donors with hepatitis B core antibody positivity is low (2003) (2)
72 Degree of End Organ Damage as a Predictor of Outcomes after Mechanical Circulatory Support Device Implantation – A More Quantitative Assessment (2011) (2)
AHA Scientific Statement Decision Making in Advanced Heart Failure (2012) (2)
269 Aortic Valve Repair at the Time of Continuous-Flow Left Ventricular Assist Device Implantation (2011) (2)
Favorable Outcomes in Dialysis Dependent Patients on LVAD BTT Support (2015) (2)
Red Cell Distribution Width (RDW) Predicts 90-Day Mortality in Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Patients (2016) (2)
234: Effect of clenbuterol on cardiac and skeletal muscle function during LVAD support (2006) (2)
LEFT VENTRICULAR LONGITUDINAL STRAIN BY SPECKLE-TRACKING ECHOCARDIOGRAPHY FOR THE DETECTION OF TREATMENT-REQUIRING REJECTION IN CLINICALLY ASYMPTOMATIC HEART TRANSPLANT RECIPIENTS (2013) (2)
Myocardial Recovery From Short- and Long-Term Cardiac Support Devices: Results From the UNOS Registry (2015) (2)
Primary Graft Failure Following Cardiac Transplantation Is Associated with Elevated Pre-Transplant Levels of Pro-Inflammatory Factors (2016) (2)
Erratum: Is percentage of predicted maximal exercise oxygen consumption a better predictor of survival than peak exercise oxygen consumption for patients with severe heart failure (Journal of Heart and Lung Transplantation (1995) 14 (981-989)) (1996) (2)
Heart Association Decision Making in Advanced Heart Failure : A Scientific Statement From the American Print (2012) (2)
Abstract 20395: High Incidence of Elevated Panel Reactive Antibodies in Patients Supported with HeartMate II Left Ventricular Assist Devices (2010) (2)
Clinical Trials The STARBRITE Trial: A Randomized, Pilot Study of B-Type Natriuretic PeptideeGuided Therapy in Patients With Advanced Heart Failure (2011) (2)
ACCF/AHA Practice Guideline: Focused Update Practice Guideline: Focused Update 2009 Focused Update: ACCF/AHA Guidelin s for the Diagnosis and Management of Heart Failure in Adults (2009) (2)
Force on Practice Guidelines, International Society for Heart and Lung American College of Cardiology Foundation/American Heart Association Task Diagnosis and Management of Heart Failure in Adults 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the (2009) (2)
Cardiac transplantation in over 2000 patients: a single-institution experience from Columbia University. (2011) (2)
Continuous‐flow mechanical circulatory support is not associated with early graft failure: An analysis of the International Society for Heart and Lung Transplantation registry (2019) (2)
Letter by Clerkin et al Regarding Article, "Importance of Routine Antihuman/Leukocyte Antibody Monitoring: De Novo Donor Specific Antibodies Are Associated With Rejection and Allograft Vasculopathy After Heart Transplantation". (2018) (1)
Acute Myocardial Failure After Liver Transplantation: Tako-Tsubo or Undiagnosed Cirrhotic Cardiomyopathy?: Abstract# D2626 (2014) (1)
Management of Comorbidities in Heart Failure (2008) (1)
Role of Erythropoietin in the Correction of Anemia in Patients with Heart Failure (2007) (1)
adult patients undergoing cardiac transplantation Prolonged donor ischemic time does not adversely affect long-term survival in (2013) (1)
Pneumonia in the First Year after Heart Transplant: Epidemiology, Risk Factors, and Effect on Survival (2010) (1)
INCREMENTAL COST OF RIGHT VENTRICULAR FAILURE AFTER LEFT VENTRICULAR ASSIST DEVICE PLACEMENT (2011) (1)
Effect of Body Mass Index on Outcomes of Heart Transplant Candidates Supported by Continuous-Flow Left Ventricular Assist Devices (CF-LVADs) (2016) (1)
Impairment of Myocardial Endocannabinoid Signaling and Depletion of the Endogenous Ligands Anandamide and Arachidonoylglycerol in Patients with Advanced Heart Failure (2011) (1)
262: Primary Graft Failure Following Heart Transplantation: Risk Factors and Outcomes (2009) (1)
686: Validation of Destination Therapy Risk Score in Recipients of Left-Ventricular Assist Devices (LVAD) at a Single Center (2009) (1)
Preoperative Screening Scale Predicts Successful Bridge to Transplantation among Chronic Congestive Heart Failure Patients (2006) (1)
Assessment of myocardial blood flow and coronary bypass graft patency during LVAD support (2003) (1)
Everolimus dose recommendations in de novo heart transplantation - TDM simulations (2003) (1)
Ablation of Ventricular Tachycardia Originating From the Papillary Muscle of the Left Ventricle Early After Heart Transplantation (2014) (1)
216 Effect of LVAD on the Prognostic Value of Baseline GFR for Long Term Renal Function in Patients Undergoing Heart Transplant (HTX) (2011) (1)
(607) - Red Cell Distribution Width Predicts 1-Year Mortality Following Heart Transplantation (2017) (1)
Serum-Derived Exosomal Proteome Analysis of Patients With Heart Failure and After Heart Transplantation (2015) (1)
Impact of Pneumonia in Heart Failure Patients. (2021) (1)
Genotype-Guided Warfarin Dosing in Continuous-Flow Left-Ventricular Assist Device (CF-LVAD) Patients (2016) (1)
513: One Year Followup with a Continuous Flow LVAD as a Bridge to Heart Transplantation (2008) (1)
Self-MHC restricted T cells specific for donor peptides infiltrate human grafts during rejection. (1997) (1)
112: The Association between Metabolic Syndrome and Long-Term Survival in Patients Undergoing Orthotopic Heart Transplantation (2010) (1)
The RADIAL Score Predicts Primary Graft Failure and Total Mortality after Heart Transplantation (2014) (1)
27-P: Anti-HLA antibodies in heart transplantation (2009) (1)
Modulation of LV Loading and Arterial Pulsatility Affects PET/CT Coronary Flow Reserve in Continuous Flow LVAD Patients (2015) (1)
SIX YEARS OF OUTPATIENT LEFT VENTRICULAR ASSIST DEVICE SUPPORT (1999) (1)
The Use of Cardiac Resynchronization Therapy in Patients Supported By Continuous-Flow Left Ventricular Assist Device (2015) (1)
The diminishing impact of pretransplant pulmonary hypertension on perioperative mortality after cardiac transplantation. (2001) (1)
Alloantibody Desensitization Therapy in Bridge-to-Transplant Patients on Continuous-Flow Left Ventricular Assist Device Support (2016) (1)
523: Higher Rates of Co-Morbidities Post Cardiac Retransplantation Contribute to Decreased Survival (2008) (1)
Left-Ventricular Assist Device Is Associated with Elevated Serum Levels of Natural IgG Reactive to Apoptotic Cells and Oxidized Epitopes (2016) (1)
581 Physical Therapy for Patients with External Ventricular Assist Device (2012) (1)
Frailty Measures of Patient-reported Activity and Fatigue May Predict 1-year Outcomes in Ambulatory Advanced Heart Failure: A Report From the REVIVAL Registry (2021) (1)
Acoustic Analysis of a Continuous-Flow Left Ventricular Assist Device before and after Suspected Pump Thrombosis (2016) (1)
The Location of Intractable Ventricular Arrhythmias Following Left Ventricular Assist Device Implantation (2015) (1)
MYOSTATIN INHIBITION AFTER EXPERIMENTAL HEART FAILURE IMPROVES CARDIAC FUNCTION AND MUSCLE WASTING (2014) (1)
Aspirin Responsiveness Predicts Mucosal Bleeding Events in Patients with Continuous-Flow Left Ventricular Assist Devices (2016) (1)
Dobutamine Stress Echocardiography to Detect Early Cardiac Allograft Vasculopathy (2016) (1)
Surgical Management of Chemotherapy-Induced End-Stage Heart Failure (2010) (1)
HEARTMATE 6: BRIDGE TO HEART TRANSPLANTATION UTILIZING BIVENTRICULAR SUPPORT FOR CARDIOGENIC SHOCK (2022) (1)
363 Continuous-Flow LVAD Destination Therapy Versus Orthotopic Heart Transplantation in Patients above 65 Years of Age (2011) (1)
Recombinant Herpes Zoster Vaccine (RZV) after Heart Transplantation: A Single Center Experience. (2020) (1)
Risk of Post-Transplant Renal Dysfunction Is Increased in Patients Supported with Continuous-Flow Left Ventricular Assist Devices (2016) (1)
Response to Letter Regarding Article “Adipose Tissue Inflammation and Adiponectin Resistance in Patients With Advanced Heart Failure: Correction After Ventricular Assist Device Implantation” (2012) (1)
FAILURE WRITING ON BEHALF OF THE 2005 HEART FAILURE WRITING GUIDELINE FOR THE MANAGEMENT OF PATIENTS WITH CHRONIC HEART (2009) (1)
Guillain-Barré Syndrome After Primary Cytomegalovirus Infection in a Patient With a Heart Transplant (2021) (1)
Association of Warfarin Genotype With Thrombosis and Bleeding Events in Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Patients (2015) (1)
Reduced myocardial blood flow during left ventricular assist device support may lead to premature closure of coronary artery bypass grafts (2003) (1)
419: Heart Transplantation in HIV Positive Patients (2009) (1)
193 The Incremental Cost of Complications after Left Ventricular Assist Device Placement (2011) (1)
Noninvasive Detection ofSkeletal Muscle Underperfusion WithNear-Infrared Spectroscopy inPatients WithHeartFailure (1989) (1)
The Proportion of BNP Decline after Left Ventricular Assist Device Implantation Predicts Length of Survival after Surgery (2010) (1)
Is the alternate waiting list too high risk? The columbia-presbyterian experience (2003) (1)
Abstract 13781: The Impact of Mechanical Unloading Through Ventricular Assist Device Placement on Cardiac ST2/IL-33 Signaling in Patients with Advanced Heart Failure (2011) (1)
Predicting the mode of death in advanced congestive heart failure (1998) (1)
Warfarin Sensitive Patients Have Higher Risk of Gastrointestinal Bleeding and Device Thrombosis on Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Support (2016) (1)
OUTCOMES OF MECHANICAL CIRCULATORY SUPPORT FOR REFRACTORY CARDIOGENIC SHOCK IN THE ERA OF MORE ADVANCED VENTRICULAR ASSIST DEVICES (2012) (1)
Cardiac Allograft Vasculopathy in HIV-Infected Patients (2013) (1)
Dynamics of Galectin-3 Levels Following Left Ventricular Assist Device Implantation (2013) (1)
192 Psychosocial Evaluation before Left Ventricular Assist Device Implantation Can Predict Device Complication during Support (2011) (1)
559 Increased Blood Pressure Variability in Patients Supported by Continuous Flow Left Ventricular Assist Devices: A Novel Vascular Phenotype in the Absence of Pulsatility? (2012) (1)
502: Geographic Changes in Waitlist Survival after Initiation of New Heart Allocation Policy (2010) (1)
Management of Chagas Cardiomyopathy Patients Following Cardiac Transplantation: Implications From the Unos Database (2015) (1)
Cardiac transplantation for the treatment of adults with congenital heart disease: a single center experience (2003) (1)
Usefulness of a Multipronged Strategy to Prevent Device Thrombosis in HeartMate II Left Ventricular Assist Devices (2016) (1)
Abnormal Skeletal Muscle Histochemistry and Enzyme Activity in Heart Failure (0426) (1989) (1)
Donna Mancini and Daniel Burkhoff Based Methods of Managing and Treating Heart Failure − Mechanical Device (2005) (0)
Impairment of Muscle Fiber Recruitment and Decreased Total Muscle Work Capacity during Isokinetic Exercise in Patients with Advanced Heart Failure (2011) (0)
Abstract 16915: Preoperative Risk Assessment of Patients with Advanced Heart Failure Evaluated for Cardiac Transplantation to Predict Survival Following Heart Transplantation (2011) (0)
Abstract 16922: Comparison of Different Strategies of LVAD Implantation for Bridging Patients to Heart Transplantation: An Analysis of the United Network for Organ Sharing (2013) (0)
Combined Renal Risk Score Predicts Post-Implant Renal Failure in Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Patients (2016) (0)
Systemic and regional hemodynamic elfects of captopril and milrinone administered alone and concomitantly in patients with heart failure (2005) (0)
PRETRANSPLANT BODY MASS INDEX IS A RISK FACTOR FOR EARLY MORTALITY AFTER HEART TRANSPLANTATION (1999) (0)
Two decades of cardiac transplantation at the Columbia-Presbyterian Medical Center: 1977-1997. (1996) (0)
(cid:1) -Blockers Restore Calcium Release Channel Function and Improve Cardiac Muscle Performance in Human Heart Failure (2003) (0)
Abstract 16687: The Incidence and Etiology of GI Bleeding in Patients Supported by Continuous Flow Left Ventricular Assist Device (2011) (0)
Generation of CD8+ CD28− T suppressor cells in heart transplant recipients (2005) (0)
Left Ventricular, Biventricular and Total Artificial Heart Support are Associated with Similar Levels of Allosensitization in Bridge-to-Transplant Patients: An Analysis of the UNOS Database (2016) (0)
330: Blood Product Requirements during Heart Transplantation Are Significantly Higher in Patients Bridged with Continuous Flow Devices Compared to Pulsatile Flow Devices (2010) (0)
Myocardial glucose utilization in cardiac transplant patients (1999) (0)
Discharge Lactate Dehydrogenase (LDH) Level Predicts Early Device Thrombosis in Patients with HEARTMATE II Left Ventricular Assist Devices: A Retrospective Cohort Analysis (2016) (0)
786 Isolated Right Ventricular Assist Device Support Does Not Predict Better Survival over Biventricular Support for Primary Graft Failure after Orthotopic Heart Transplant (2012) (0)
Mechanical Unloading Via Left Ventricular Assist Device Implantation Ameliorates Adipose Tissue Inflammation and Increases Adipocyte Size in Patients With Advanced Heart Failure (2011) (0)
Changes in Lipid Profile Subfractions on Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Therapy (2016) (0)
CONGESTIVE HEART FAILURE Systemic and regional hemodynamic elfects of captopril and milrinone administered alone and concomitantly in patients with heart failure (0)
Use of Phosphodiesterase 5 Inhibitors in Continuous-Flow Left Ventricular Assist Device Patients With Pulmonary: Hypertension: A Contemporary Analysis (2015) (0)
Safety of Mechanical Circulatory Support as a Bridge to Cardiac Retransplantation (2014) (0)
An Evaluation of IgG, C1q and CDC in Detection of Anti-HLA Antibodies in Incidence of AMR in Heart Allograft Recipients (2015) (0)
AN IMMUNOLOGICALLY-GUIDED APPROACH SAFELY REDUCES BIOPSY FREQUENCY IN CARDIAC TRANSPLANTATION (1999) (0)
Abstract 19882: Ventricular Assist Device Implantation Corrects Impairment of Growth Hormone/Insulin-like Growth Factor-1 Signaling in Patients with Advanced Heart Failure (2010) (0)
Expanding the donor pool: Acceptable recipient outcomes with the use of hearts from donors with hepatitis B core antibody positivity or intracranial tumors (2003) (0)
Abstract 10318: Liver Dysfunction and Dynamics in Liver Function Parameters Predict Survival of Patients with Advanced Heart Failure Requiring Ventricular Assist Device Placement (2011) (0)
Atrial Fibrillation in Patients Supported by Continuous-Flow Left Ventricular Assist Device (2014) (0)
8: Development of Aortic Insufficiency in Patients Supported with a HeartMate II Left Ventricular Assist Device (LVAD) (2010) (0)
Clonal Composition and Specificity of Graft Infiltrating B Cells in Human Cardiac Allograft Vasculopathy (2015) (0)
Effects of Hospital Characteristics on In-Hospital Mortality and Hospitalization Costs for Mechanical Circulatory Support Device (MCSD) Therapy: Results from the National (Nationwide) Inpatient Sample (NIS) (2017) (0)
Continuous Flow Left Ventricular Assist Device as a Risk Factor for Intraoperative Vasoplegia during Orthotopic Heart Transplantation (2016) (0)
275: Does renal function deteriorate more rapidly in diabetic transplant recipients than in normal recipients? (2006) (0)
Poster session62-P: Significance of anti-HLA antibodies detected by solid-phase assay in heart allograft recipients (2009) (0)
Diagnosis of Heart Failure (2019) (0)
533 Analysis of Long-Term Outcome of Patients with Cardiac Sarcoidosis Undergoing Heart Transplantation (2011) (0)
Abstract 16193: Impaired Cardiac and Skeletal Muscle Lipid Metabolism and Reduced Cardiac Fatty Acid and Triglyceride Levels in Patients With Advanced Heart Failure (2011) (0)
Abstract 13707: Increased Bone Turnover and Resorption in Patients with Advanced Heart Failure is Corrected by Hemodynamic Improvement Through Ventricular Assist Device Implantation (2011) (0)
INCREASED INSULIN SENSITIVITY IN ADVANCED HEART FAILURE PATIENTS TREATED WITH LEFT VENTRICULAR ASSIST DEVICE (2010) (0)
Abstract 16561: Mechanical Unloading via Left Ventricular Assist Device Implantation Ameliorates Systemic and Adipose Tissue Inflammation and Increases Adipocyte Size in Patients With Advanced Heart Failure (2011) (0)
Effect of Device Thrombosis and Malfunction on Clinical Outcomes of Patients Bridging With Continuous-Flow LVADs (2015) (0)
333: Center experience and outcomes of left-ventricular assist device (LVAD) implantation as destination therapy (DT) – analysis of thoratec DT registry 1998-2005 (2007) (0)
Abstract 13291: Left Ventricular Assist Device Support is Associated with Sustained Cardiac CamKII Activation and Increased MEF2 (2014) (0)
281: Ventricular Assist Devices as Successful Bridge to Cardiac Re-Transplantation in Late Graft Failure: The Columbia-Presbyterian Experience (2009) (0)
461 Recovery of Lipid Metabolism after Left Ventricular Assist Device Placement Predicts Short- and Long-Term Survival in End-Stage Heart Failure Patients (2011) (0)
Discriminatory Performance of Simple Urine Dipstick for Detection of Significant Hemolysis in CF-LVAD Patients (2015) (0)
Does Indication for LVAD at Time of Implant Matter in Younger Patients? (2019) (0)
Prospective Evaluation of Urine Dipstick for Detection of Significant Hemolysis in Outpatients on CF-LVAD Support (2016) (0)
(534) – Dobutamine Stress Echocardiography to Detect Early Cardiac Allograft Vasculopathy (2016) (0)
ASSESSMENT OF SYNCHRONY BETWEEN THE NATIVE LEFT VENTRICLE AND THE TCI HEARTMATE LEFT VENTRICULAR ASSIST DEVICE (1999) (0)
Abstract 16438: Serum Exosomal Protein Profiling for the Non-invasive Detection of Cardiac Allograft Rejection (2015) (0)
Long-Term Outcomes in Continous-Flow Left Ventricular Assist Device Patients with and without ICD (2016) (0)
656 Similar Survival in Patients Following Heart Transplantion Receiving Induction Therapy Using Daclizumab Versus Basiliximab (2012) (0)
Editorial Board (2011) (0)
ITO and IR potassium channel (K+) expression and regulation during severe left ventricular dysfunction (LVD) and ventricular unloading (2003) (0)
Abstract 19648: Exposure to Ionized Medical Radiation after Heart Transplant is Associated with Higher Risk of Malignancies (2012) (0)
318: Anti-HLA antibodies in heart transplantation (2006) (0)
Abstract 19327: Reduced Handgrip Strength Predicts Clinical Outcomes in Patients with Advanced Heart Failure Undergoing Ventricular Assist Device Placement (2012) (0)
414: The effect of clenbuterol on skeletal muscle, cardiac function and exercise capacity in patients with chronic heart failure (2007) (0)
Feasibility of 24-Hour Advanced Ambulatory Blood Pressure and Hemodynamic Monitoring in Patients with Continuous-Flow Left Ventricular Assist Device (2016) (0)
Arrhythmia History Predicts Morbidity and Mortality Following LVAD Implantation (2016) (0)
EFFECT OF CONVERSION FROM CALCINEURIN INHIBITORS (CNIS) TO SIROLIMUS ON RENAL FUNCTION IN CARDIAC TRANSPLANT RECIPIENTS WITH MILD TO MODERATE RENAL INSUFFICIENCY: INTERIM SAFETY AND EFFICACY RESULTS: 1193 (2010) (0)
Safety and effects of SGLT-2 inhibitor use among LVAD patients with type 2 diabetes mellitus (2022) (0)
585 Aspergillus Infection after Heart Transplantation: Risk Factors, Clinical Course and Outcomes (2011) (0)
Table of Contents (2020) (0)
SURVIVAL AFTER HEART TRANSPLANTATION: ARE PRETRANSPLANT RISK FACTORS IMPORTANT? (1999) (0)
(193) - Impact of Center Volume on Bridging to Transplantation with Contemporary Left Ventricular Assist Devices (2017) (0)
249: A Randomized, Open-Label Study To Compare the Safety and Efficacy of Conversion From a Calcineurin Inhibitor (CNI) to Sirolimus Versus Continued Use of a CNI in Cardiac Transplant Recipients with Mild to Moderate Renal Insufficiency (2010) (0)
210 Impact of Continuous Versus Pulsatile Unloading Pattern on Myocardial Matrix Biomarkers in Patients with Left Ventricular Assist Device (2011) (0)
Outcome in Chronic Heart Failure Peak Cardiac Power Output , Measured Noninvasively (2009) (0)
Late-onset T-cell activation and cardiac allograft rejection following cessation of daclizumab induction therapy (2005) (0)
Dilutional anemia in patients with advanced heart failure is associated with poor outcome (2003) (0)
217 Risk-Stratification of Heart Transplant (HTX) Candidates with Advanced Liver Dysfunction (2011) (0)
ASSOCIATION OF MEDICAID EXPANSIONS WITH ACCESS TO HEART TRANSPLANTATION AND VENTRICULAR ASSIST DEVICE THERAPY (2016) (0)
MESENCHYMAL PRECURSOR CELLS IN LVAD RECIPIENTS: DOES HF ETIOLOGY MAKE A DIFFERENCE? (2020) (0)
OPTICAL COHERENT TOMOGRAPHY EVALUATION OF TRANSPLANT CORONARY ARTERY VASCULOPATHY WITH AND WITHOUT HISTORY OF CELLULAR REJECTION (2013) (0)
584 Pneumonia in the First Year Post-Cardiac Transplant Is Common and Associated with Reduced Long Term Survival (2011) (0)
Comparison of Early Versus Delayed Left Ventricular Assist Device Implantation in Patients Bridged to Heart Transplantation (2014) (0)
Peripheral vascular disease adversely affects survival for cardiac transplant recipients (2004) (0)
Hepatic Dysfunction and MELD Score Improve After Orthotopic Heart Transplantation and Predict Post-Transplantation Mortality (2010) (0)
Abstract 15634: Effect of Perioperative Atrial Fibrillation in Orthotopic Heart Transplant Recipients on Short and Long Term Mortality (2011) (0)
High Mortality With Acute Kidney Injury After Mechanical Support for Cardiogenic Shock (2015) (0)
Cardiac Donor Characteristics Predictive of One Year Post-Heart Transplant Mortality: Analysis of the UNOS Transplant Database (2015) (0)
The Power of Cardiac Output. (2019) (0)
46-OR: 15-year actuarial survival of heart allografts in patients monitored for anti-HLA antibodies before and after transplantation (2011) (0)
Incidence and Predictors of Left Ventricular Functional Recovery on Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Support (2016) (0)
The Incidence and Etiology of Gastrointestinal Bleeding in Patients Supported by the HeartMate II Continuous Flow Left Ventricular Assist Device: 1094 (2011) (0)
Deep Sequencing Reveals Dynamics in Circulating miRNAs Following Heart Transplantation (2015) (0)
1050-121 Echocardiographic, electrophysiological, histological, and serological recovery during left ventricular assist device support (2004) (0)
366 Pre-Transplant MELD-XI Scores Predict Long-Term Survival after Orthotopic Heart Transplantation (OHT) in the UNOS Registry (2011) (0)
Abstract 13929: Mechanical Unloading Through Left Ventricular Assist Device Implantation Reduces Endoplasmic Reticulum Stress and Improves Calcium Handling in Patients With Advanced Heart Failure (2013) (0)
Outcomes of Patients Complicated With Late Right Heart Failure During Continuous Left Ventricular Device: Support: Should Patients Stay on Device or Be Transplanted? (2015) (0)
DIFFERING PATTERNS OF MYOSTATIN SIGNALING REGULATE HYPERTROPHY IN SEVERE AORTIC STENOSIS AND HYPERTROPHIC CARDIOMYOPATHY (2014) (0)
308: Serum Albumin Concentration as Predictor of Mortality in Patients with End Stage Heart Failure Treated Medically and with Mechanical Circulatory Support – Analysis of the UNOS/OPTN Data and the DT Thoratec Registry – Years 1999-2007 (2009) (0)
Heart transplantation in diabetic recipients: a decade review of 161 patients at columbia presbyterian (2003) (0)
Micro-RNA-451 and Measures of Hemolysis Associated with Left Ventricular Assist Device Implantation (2013) (0)
168: Neurocognitive Evaluation of Patients Receiving Continuous Flow Left Ventricular Assist Devices (LVADs) (2008) (0)
LISTING OLDER PATIENTS FOR TRANSPLANT OR OFFERING LVAD DESTINATION THERAPY? (2019) (0)
Statement From the American Heart Association Clinician's Guide to Cardiopulmonary Exercise Testing in Adults. A Scientific (2010) (0)
MELD XI Successfully Predicts Thirty Day Mortality in Patients Who Received Centrimag VAD for Acute Decompensated Heart Failure (2015) (0)
105: Tight perioperative glucose control is associated with fewer LVAD related infections and better post-VAD survival (2006) (0)
654 Outcome of Patients with Postcardiotomy Shock Requiring Ventricular Assist Device Support Remains Poor (2011) (0)
56 Safety and Efficacy of Conversion to Sirolimus vs Continued Calcineurin Inhibitor Use in Cardiac Transplant Recipients with Renal Insufficiency (2011) (0)
3-OR: Relationship between cardiac allograft rejection and T suppressor cells (2006) (0)
313: Outcomes of Medical Therapy and Mechanical Circulatory Support as Bridge to Transplantation in UNOS Status 1 Heart Transplant Candidates – Analysis of the U.S. UNOS/OPTN Data, Years 1999-2007 (2009) (0)
549: Additional Procedure to Aortic Valve at LVAD Placement (2010) (0)
The Value of Elective Status 1A Time and the Effects of Delayed Transplant Listing Among Registrants With Mechanical Circulatory Support (2015) (0)
Skeletal Muscle Dysfunction and Deconditioning in Heart Failure (2009) (0)
Electrical Remodeling After Continuous-Flow Left Ventricular Assist Device Implantation (2016) (0)
Reply (2020) (0)
449 The Outcome of Patients with Idiopathic Non-Dilated Hypertrophic Cardiomyopathy Following Cardiac Transplantation (2012) (0)
Inflammation Mediated Fibrosis Is Regulated Through Distinct Gene-Gene Co-Expression Networks in the Failing Human Myocardium Before and After Left Ventricular Assist Device Support (2015) (0)
297: Sensitization in axial flow devices versus pulsatile left ventricular assist devices (2006) (0)
Abstract 20054: Myocardial Expression and Circulating Serum Levels of the Extracellular Matrix Markers MMP-2, MMP-9 and Osteopontin in Patients with Advanced Heart Failure Undergoing Ventricular Assist Device Placement (2010) (0)
Variability in Gene Expression Profiling (GEP) Identifies Heart Transplant Recipients at Risk for Acute Cellular Rejection but Not Cardiac Allograft Vasculopathy (2017) (0)
Peak Cardiac Power Measured Non-Invasively With a Bioreactance Technique is a Predictor of Adverse Outcomes in Patients With Advanced Heart Failure (2010) (0)
Comparison of Outcomes Following Heart Replacement Therapy in Patients Over 65 Years Old (2015) (0)
Abstract189: The changing pattern of humoral rejection in cardiac transplant recipients (2006) (0)
183: The Impact of Implantable Cardiac Defibrillator (ICD) on Survival of UNOS Status 2 Candidates for Heart Transplantation (HT) – Analysis of UNOS/OPTN Data 2000-2006 (2008) (0)
89: Relationship between cardiac allograft vasculopathy and expression of ILT3, ILT4 and FOXP3 in endomyocardial biopsies (2006) (0)
The Impact of Acute Kidney Injury in Patients With Postcardiotomy Cardiogenic Shock Requiring Mechanical Circulatory Support (2015) (0)
What is the relationship between cardiac and peripheral ghrelin production? Reply (2009) (0)
Abstract 20164: Profiling of Circulating MicroRNAs After Heart Transplantation and During Acute Cellular and Antibody-Mediated Rejection (2014) (0)
Impact of Socioeconomic Status on Bridging with Contemporary Left Ventricular Assist Device (LVAD): Analysis of the UNOS Registry (2016) (0)
The Impact of Concomitant Mitral Repair in Patients Receiving Continuous-Flow Left Ventricular Assist Devices (2015) (0)
Long Term Left Ventricular Assist Device as Bridge to Heart Transplantation: De Facto Destination Therapy in Many? (2010) (0)
45: The association between body mass index and long term survival in patients undergoing heart transplantation (2006) (0)
Reply What Happened to Electrocardiogram as a Screening Test to Recognize Cardiovascular Complications in COVID-19 Patients? (2020) (0)
Safety and Efficacy of Pre Transplant Desensitization of Patients Supported by CF-LVADs (2014) (0)
Hepatic Function After Long-Term Continuous-Flow Left Ventricular Assist Device Support (2015) (0)
Advanced Kidney Disease Limits LVAD Survival (2019) (0)
INFLUENCE OF ABO BLOOD TYPE MATCHING ON SURVIVAL OF CARDIAC TRANSPLANT RECIPIENTS. (1999) (0)
arterial and mixed venous blood during exercise Carbon dioxide pressure-concentration relationship in (2015) (0)
(264) - Bridging to Transplantation with Contemporary Continuous-Flow Left Ventricular Assist Devices: A Decade Experience (2017) (0)
Abstract 13748: Prolonged Muscle Fiber Recruitment Intervals and Impaired Skeletal Muscle Work Capacity in Patients With Advanced Heart Failure (2011) (0)
Abstract 18617: Development of Aortic Root Dilation is Accompanied by Increased Vascular Expression of Proinflammatory Adhesion Molecules VCAM, ICAM and E-Selectin in Patients with Advanced Heart Failure Following Left Ventricular Assist Device Placement (2012) (0)
421 Elevations in Donor Troponin Levels Do Not Predict Worse Outcomes Following Orthotopic Heart Transplant (2012) (0)
Recipient and Donor Risk Factors Associated with Primary Graft Failure Requiring Temporary Mechanical Circulatory Support < 24 Hours After Heart Transplantation (2016) (0)
Signal-averaged electrocardiography in patients with nonischemic dilated cardiomyopathies (1993) (0)
Perceived Control: A Target for Improving Psychosocial Outcomes Early After Heart Transplant (2014) (0)
Comparison of Exercise Hemodynamics in Patients Supported with Centrifugal and Axial Flow Left Ventricular Assist Devices (2019) (0)
Reduced Long-term Outcomes after Orthotopic Heart Transplantation in Septuagenarians (2014) (0)
Estimated Health Care Utilization and Expenditures in Individuals With Heart Failure From the Medical Expenditure Panel Survey (2021) (0)
Abstract 13311: Low Serum Albumin Concentration is Associated With Poor Post-Transplant Prognosis in Patients Undergoing Heart Transplantation (2011) (0)
TCT-668 OCT Assessment Of The Differences Between Native Coronary Atherosclerosis And Cardiac Allograft Vasculopathy (2013) (0)
Abstract 18562: Severity of Posterior Coaptation Displacement of the Anterior Mitral Leaflet Contributes to Irreversibility of Mitral Regurgitation Following Left Ventricular Assist Device Placement (2012) (0)
Abstract 17275: The SGLT2 Inhibitor Empagliflozin Ameliorates Left Atrial Dilatation in Non-Diabetic Patients With Heart Failure With Reduced Ejection Fraction: A Secondary Analysis of the EMPATROPISM Trial (2020) (0)
Drug treatment of clinical problems related to cardiac transplantation. (2002) (0)
106 Serial Echocardiographic Evaluation Using 2-Dimensional Speckle Tracking Imaging in Monitoring Right Ventricular Failure Development Following Left Ventricular Assist Device Implantation (2012) (0)
(392) – Attenuation of Cardiac Allograft Vasculopathy in Dual Organ Transplantation (2017) (0)
74 Pre- and Post-Operative Risk Factors Associated with Neurological Complications in Patients Supported by Ventricular Assist Device (2011) (0)
Effect of rapamycin on anti-HLA donor antibody formation in patients with transplant coronary artery disease (2003) (0)
467 Generally Accessible Echocardiographic Parameters of Left Heart Could Predict Right Heart Failure after Left Ventricular Assist Device Implantation (2011) (0)
243: Survival in Men and Women with Left Ventricular Ejection Fraction Lower Than 30% Referred for Orthotopic Heart Transplantation (2008) (0)
Mechanical unloading leads to echocardiographic, electrophysiological, histological and serological recovery (2004) (0)
453 The Prevalence of Chronic Kidney Disease before and after Orthotopic Heart Transplant: Does the Degree of eGFR Decline Proportionally Translate into Poorer Patient Outcomes? (2012) (0)
Abstract 18813: Outcomes of Patients with Congenital Heart Disease following Heart Transplantation: the Impact of Disease Type, Prior Thoracic Surgeries and End-Organ Dysfunction (2014) (0)
282: Do peak VO2 and the heart failure survival score predict prognosis in women? (2006) (0)
Changes in Left and Right Ventricular Function Before and After Lung Transplantation: Serial Echocardiographic Assessment (2014) (0)
Increasing Use of Mechanical Circulatory Support as a Bridge to Cardiac Retransplantation (2014) (0)
SAFETY, TOLERABILITY, AND EFFICACY OF CYCLOSPORINE MICROEMULSION IN HEART TRANSPLANT RECIPIENTS: A RANDOMIZED, MULTICENTER, DOUBLE-BLIND COMPARISON WITH THE OIL-BASED FORMULATION OF CYCLOSPORINE—RESULTS AT 24 MONTHS AFTER TRANSPLANTATION1 (2001) (0)
Xenon-133 determination of muscle blood flow: Use in evaluating cardioactive drugs (1985) (0)
Therapy to prevent osteoporosis may be discontinued one year after heart transplantation in patients with normal bone density (2004) (0)
(374) - Risk of Early Graft Failure Following Heart Transplantation with Durable Continuous Flow vs. Pulsatile Flow Mechanical Circulatory Support (2017) (0)
Heart Failure Update (2005) (0)
Abstract 16600: Prognostic Value of Peak Exercise Oxygen Consumption and Bnp Levels in Ambulatory Patients With Advanced Heart Failure Undergoing Evaluation for Heart Transplantation (2011) (0)
636 Ventricular Assist Device Support as a Bridge to Heart Transplantation in Patients with Giant Cell Myocarditis (2011) (0)
New Insights in Cardiac Allograft Vasculopathy by Near-Infrared Spectroscopy (2014) (0)
Ability to Obtain Blood Pressure Readings By Standard Automated Blood Pressure Monitor Helps Interpreting the Relationship Between Doppler Blood Pressure to Systolic Blood Pressure and Mean Arterial Pressure (2015) (0)
Infectious Complications after Cardiac Transplantation in Patients Bridged to Transplantation with Mechanical Circulatory Support Devices Versus Medical Therapy (2016) (0)
755 Reduced Handgrip Strength as a Marker of Patient Frailty Predicts Worse Survival after Implantation of a Left Ventricular Assist Device (2012) (0)
364 Increased Vascular Expression of the Proinflammatory Adhesion Molecules VCAM and E-Selectin and Endothelial Depletion of vWF Following Continuous Flow Left Ventricular Assist Device Placement (2012) (0)
Durability and Clinical Impact of Tricuspid Valve Procedures in Patients Receiving Continuous-Flow Left Ventricular Assist Device (2015) (0)
Comparison of Heart Replacement Therapy in Patients Over 65 Years Old (2014) (0)
465 Mechanical Unloading through Ventricular Assist Device Implantation Corrects Adiponectin Resistance in Patients with Advanced Heart Failure (2011) (0)
Abstract 18488: The Impact of Mechanical Circulatory Support Type for Bridge-to-Transplantation on Post-transplant Prognosis: An Analysis of the United Network for Organ Sharing (UNOS) (2012) (0)
47 Parametric Prediction Model Using Preoperative Serum Albumin Concentration for Survival Estimation in Patients Undergoing Heart Transplantation (2012) (0)
Abstract 19732: Ventricular Assist Device Implantation Corrects Myocardial Lipotoxicity, Reverses Insulin Resistance and Normalizes Cardiac Metabolism in Advanced Heart Failure (2010) (0)
Loeffler's Endocarditis Treated with Total Artificial Heart as Bridge to Transplant (2021) (0)
Hemolysis Does Not Lead to Increased Discordance between Measured APTT and ANTI-XA Levels in Patients with Continuous-Flow Left Ventricular Assist Devices (2016) (0)
527 Analysis of Impaired Liver Function through Different MELD Scores for Prediction of Long-Term Survival after Orthotopic Heart Transplantation (2011) (0)
Survival in Cardiac Amyloid Using Extended Donor Organs in Comparison to Transplantation for Other Indications (2008) (0)
3: UNOS status at the time of heart transplantation predicts long-term survival (2006) (0)
Effect of the 2006 U.S. Donor Heart Allocation Policy Change on Waitlist Complications and Post-Transplant Mortality Among Candidates Supported With Mechanical Circulatory Support (2015) (0)
The New Heart Allocation System: Implications on Patients with Restrictive Cardiomyopathy in the UNOS Registry (2017) (0)
QRS Duration Predicts Outcomes Following Implantation of a Left Ventricular Assist Device (2016) (0)
471: Combined Heart Kidney Retransplant Has Lower Survival than De Novo Transplant (2010) (0)
The Administration of Subcutaneous Erythropoietin in Elderly Patients with Heart Failure and a Normal Ejection Fraction over Three Months Is Safe and Effective (2006) (0)
463: RVSWI Is an Independent Predictor of Need for MCS and/or HT in Stable Outpatients with NYHA Class III HF (2010) (0)
Erratum to: Ventricular assist device implantation improves skeletal muscle function, oxidative capacity, and growth hormone/insulin-like growth factor-1 axis signaling in patients with advanced heart failure (2014) (0)
Long-Term Outcome of Cardiac Transplant After Continuous-Flow Left Ventricular Assist Device Support (2014) (0)
Abstract 11930: Late Right Heart Failure During Continuous-Flow Left Ventricular Assist Device Support Adversely Affects Post-Transplant Outcome (2014) (0)
36 Right-to-Left Hemispheric Predominance of Cerebrovascular Lesions and Its Association with Systemic Infection in Patients Undergoing Left Ventricular Assist Device Implantation (2012) (0)
83-P Cylex immune function assay in heart transplantation (2011) (0)
21-P: Allosensitization on Heart Allograft Recipients (2010) (0)
Heart Failure Ventricular Assist Device Implantation Corrects Myocardial Lipotoxicity, Reverses Insulin Resistance, and Normalizes Cardiac Metabolism in Patients With Advanced Heart Failure (2012) (0)
(249) - Prolonged Support Is Associated with Increased Risk of Cellular Rejection in Patient's Bridged to Transplantation with Continuous Flow Left Ventricular Assist Devices (2017) (0)
CI-930, a new cardiotonic and vasodilating agent: hemodynamic comparison to dobutamine and long-term clinical effects. (1988) (0)
Impact of LVAD speed change on physiologic functions. (2019) (0)
INCREASED INCIDENCE OF AORTIC INSUFFICIENCY IN HEARTMATE II COMPARED TO HEARTMATE I LEFT VENTRICULAR ASSIST DEVICE RECIPIENTS (2010) (0)
Editorial Board (2010) (0)
Exercise and Patients with Heart Failure (2017) (0)
149: Incidence of De Novo Solid Malignancies after Heart Transplantation Is Comparable to the General Population (2008) (0)
489 Metabolic Syndrome Is Significantly Associated with Cardiac Allograft Vasculopathy: The Influence of Modifiable Risk Factors on Mortality in Patients Undergoing Orthotopic Heart Transplantation (2012) (0)
792 Feasibility and Flexibility of Magnetically Levitated Centrifugal-Flow Pump for Patients with Cardiogenic Shock (2012) (0)
Stroke Subtype Impacts Outcomes and Transplant Eligibility in CF-LVADS (2015) (0)
Contents (2020) (0)
732 Preoperative Hypoalbuminemia Predicts Poor Prognosis in Patients Undergoing Left Ventricular Assist Device Implantation (2012) (0)
Primary Graft Dysfunction After Cardiac Transplantation Following Continuous-Flow Left Ventricular Device Support (2015) (0)
Factors Contributing to t art Failure (2016) (0)
Increased Levels of Osteopontin Are Associated with Development of Right Ventricular Failure after Ventricular Assist Device Implantation in Patients with Advanced Heart Failure (2011) (0)
Chapter 19 – Alterations in Diaphragmatic and Skeletal Muscle in Heart Failure (2011) (0)
RE: "Is there a difference between patients with peak oxygen consumption below 10 ml/kg/min versus between 10 and 14 ml/kg/min? Does the "grey zone" really exist?". (2011) (0)
676 New Onset Atrial Fibrillation and Atrial Flutter after Cardiac Transplant Is Associated with High Mortality and Cardiac Allograft Vasculopathy (2012) (0)
CORONARY ARTERY BYPASS GRAFTS CLOSE PREMATURELY AFTER LVAD IMPLANTATION WHICH MAY BE RELATED TO REDUCED MYOCARDIAL BLOOD FLOW AND METABOLISM (2001) (0)
Added Value of Molecular Microscope Diagnostic System (mmdx) to Established Indicators of Heart Transplant Rejection: A Single Center Experience (2023) (0)
VKORC1 Genotype Predicts Warfarin Dosing and INR Kinetics in Patients With Continuous-Flow Left Ventricular Assist Devices (CF-LVADs) (2015) (0)
ALLOSPECIFIC T REGULATORY AND T SUPPRESSOR CELLS IN TRANSPLANTATION (2004) (0)
Abstract 15702: Neutrophil Gelatinase-associated Lipocalin (NGAL) Correlates With Impaired Renal Function In Patients With Advanced Heart Failure And Corrects After Ventricular Assist Device Placement (2011) (0)
Abstract 2309: Evaluation of discrimination and calibration of the Heart Failure Survival Score and Seattle Heart Failure Model in ambulatory patients evaltuated for cardiac transplant. (2007) (0)
Abstract 19271: Lack of Sufficient Pulsatile Flow in the Microvasculature May Contribute to Increased Microvascular Complications in Patients Implanted With Continuous Flow Left Ventricular Assist Devices (2015) (0)
357: Acquired Von Willebrand Disease Frequently Occurs in Continuous Flow Left Ventricular Assist Devices (2010) (0)
9: Use of Mechanical Support Devices in Patients with Mechanical Mitral Valve Prosthesis (2010) (0)
Relationship of Factor II and Factor X Activity with International Normalized Ratio (INR) in Continuous-Flow Left Ventricular Assist Device (CF-LVAD) Patients: A Cross-Sectional Study (2016) (0)
422: Clinical Outcome of Orthotopic Heart Transplantation for End-Stage Heart Disease Due to Mediastinal Radiation Therapy (2009) (0)
THE COMPARISON BETWEEN CARDIAC ALLOGRAFT VASCULOPATHY AND ATHEROSCLEROSIS DETECTED BY NEAR-INFRARED SPECTROSCOPY (2014) (0)
Reliability of a Novel Slow Cuff-Deflation System for Non-Invasive Blood Pressure Monitor in Out-Patients with Continuous-Flow Left Ventricular Assist Devices (2011) (0)
486: Cognitive Impairment in Heart Failure: It Is More Than Just Depression (2008) (0)
The Predictive Power of Invasive Hemodynamics and MELD Scores in Ambulatory Patients With Advanced Heart Failure (2014) (0)
412: Gender related considerations in patients referred for heart transplant evaluation (2007) (0)
381 Whoa Baby! Successful Vaginal Delivery in a Woman with a Dilated Cardiomyopathy Supported with a Left Ventricular Assist Device (2011) (0)
Abstract 13812: Preoperative Risk Assessment of High Risk Heart Transplantation Candidates to Predict Survival Following Heart Transplantation (2011) (0)
Response to letter regarding article, "Value of peak exercise oxygen consumption combined with B-type natriuretic peptide levels for optimal timing of cardiac transplantation". (2013) (0)
Abstract 14780: The First Hundred Days: Gender Differences in Psychosocial Distress After Heart Transplant (2015) (0)
Abnormal Thyroid Function in Patients With Advanced Heart Failure Reverses after Heart Transplantation (2010) (0)
Excessive ventilatory response to exercise persists following cardiac transplantation (1991) (0)
466 Ventricular Assist Device Implantation Corrects Systemic and Peripheral Impairment of Growth Hormone/Insulin-Like Growth Factor-1 Signaling in Patients with Advanced Heart Failure (2011) (0)
Ventricular Assist Device Implantation Corrects Skeletal Muscle Function, Oxidative Capacity and Local Expression of Insulin-Like Growth Factor-1 in Patients with Advanced Heart Failure (2011) (0)
85: Semi-Supervised Approach to Risk Evaluation in Stage-D Heart Failure Patients Referred for Heart Transplantation (2009) (0)
The Effect of Erythropoietin on Left Ventricular Remodeling and Pressure-Volume Relationships in Patients with Anemia and Heart Failure Normal Ejection Fraction (HFNEF) (2007) (0)
Selective Low-level Leg Muscle Training Alleviates Dyspnea in Patients with Heart Failure. (2003) (0)
HIGH PREVALENCE OF BLEEDING WITH CONTINUOUS FLOW DEVICES (2010) (0)
Abstract 19470: Sustained Improvement in Clinical Outcomes with MYDICAR® Compared to Optimal Therapy 1-year after Initial Gene Therapy in Patients with Advanced Heart Failure-The CUPID Trial (2010) (0)
Use of Circulatory Arrest During Heart Transplantation Does Not Worsen Perioperative Survival (2015) (0)
Five -Fold Increase in Antibody-Mediated Rejection (AMR) Post-Heart Transplant in Patients Developing Allosensitization During Left Ventricular Assist Device Support (LVAD) (2014) (0)
Long-Term Survival After Cardiac Retransplantation: A Twenty-Year Single-Center (2013) (0)
Pulse oximetry saturation levels in chronic respiratory failure patients during unsedated trans-nasal gastroscopy (2001) (0)
Abstract 16061: Effects of UNOS Policy Changes on Market Competition and Heart Transplant Outcomes (2015) (0)
Total Depletion and Abnormal Composition of Myocardial Free Fatty Acid Stores in Patients With Advanced Heart Failure (2011) (0)
eart Allograft Rejection: Detection With Breath Alkanes in Low evels (the HARDBALL Study) (2004) (0)
Abstract 18438: Long Term Left Ventricular Assist Device as Bridge to Heart Transplantation -- is it Really a Bridge? (2010) (0)
(887) - Mechanical Circulatory Support Devices (MSCD) Therapy in the Era of the Affordable Care Act (ACA): National Trends in Hospitalization Costs and In-Hospital Mortality (2017) (0)
Abstract 14275: Improvement of Skeletal Muscle Function and Oxidative Capacity, Systemic Inflammation and Growth Hormone/Insulin-Like Growth Factor-1 Signaling in Patients With Advanced Heart Failure Following Ventricular Assist Device Implantation (2011) (0)
The Impact of Late Antibody Mediated Rejection with Graft Dysfunction on Cardiac Allograft Vasculopathy and Survival (2016) (0)
Reduced Serum Albumin Concentration before Heart Transplantation Predicts Poor Post-Transplant Prognosis (2011) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Donna M. Mancini?

Donna M. Mancini is affiliated with the following schools:

Donna M. Mancini's Academic­Influence.com Rankings

Why Is Donna M. Mancini Influential?

Donna M. Mancini's Published Works

Published Works

What Schools Are Affiliated With Donna M. Mancini?

Donna M. Mancini's AcademicInfluence.com Rankings